Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Recurrent Ewing Sarcoma"'
Autor:
Anderson B. Collier, Mark Krailo, Steven G. DuBois, Lisa Bomgaars, Mark L. Bernstein, Damon R. Reed, Ha Dang, Richard Gorlick, Katherine A. Janeway, Douglas S. Hawkins
Publikováno v:
Pediatr Blood Cancer
Seven Children’s Oncology Group phase 2 trials for patients with relapsed/progressive solid tumors were analyzed to estimate the event-free survival (EFS) for relapsed/progressive Ewing sarcoma. One hundred twenty-eight Ewing sarcoma patients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56a88d1e2fd5626bca062cbbdb1ae42
https://doi.org/10.1002/pbc.29333
https://doi.org/10.1002/pbc.29333
Autor:
Lars M. Wagner, David Van Mater
Publikováno v:
OncoTargets and Therapy. 12:2279-2288
Although many patients with newly diagnosed Ewing sarcoma can become long-term survivors, relapse remains an important clinical problem for which there is no standard approach. Several prognostic factors have been identified, and these may help guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb3b87347d5da2c8257bd3cab6ad88b
https://doi.org/10.2147/ott.s170585
https://doi.org/10.2147/ott.s170585
Autor:
Keita Fukushima, Robert Nakayama, Masaya Nakamura, Osahiko Tsuji, Morio Matsumoto, Satoshi Nori, Eijiro Okada, Narihito Nagoshi, Kota Watanabe, Satoshi Suzuki, Mitsuru Yagi, Katsura Emoto
Publikováno v:
Spinal Cord Ser Cases
INTRODUCTION: Intramedullary metastasis of Ewing sarcoma is extremely rare. Here, we report an adult case of cervical intramedullary recurrent Ewing sarcoma after a 10-year disease-free survival after the initial surgery for a thoracic lesion. CASE P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5cdb218c35425fa9461a16719aab05
https://doi.org/10.1038/s41394-021-00406-5
https://doi.org/10.1038/s41394-021-00406-5
Autor:
Sarah Dumont, Judith Landman-Parker, Marie-Cécile Le Deley, Nathalie Gaspar, Gilles Vassal, Maud Toulmonde, Arthur Felix, Pablo Berlanga
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 5, Pp 1589-1604 (2021)
Cancer Medicine, Vol 10, Iss 5, Pp 1589-1604 (2021)
Background Optimal Phase‐II design to evaluate new therapies in refractory/relapsed Ewing sarcomas (ES) remains imperfectly defined. Objectives Recurrent/refractory ES phase‐I/II trials analysis to improve trials design. Methods Comprehensive rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94cb2d9e11371e1c85812bd58b6f856
https://pubmed.ncbi.nlm.nih.gov/33452711
https://pubmed.ncbi.nlm.nih.gov/33452711
Autor:
George T. Calvert, Joseph D. Femino, Clarke P. Anderson, Jerry C. Cheng, Nicole Karras, Julie DiMundo, Joseph Rosenthal, Judith K. Sato, Anna B. Pawlowska, Dongyun Yang, Andrew Dagis, J'Rick Lu, Victoria Sun, James S. Miser
Publikováno v:
Transplantation and cellular therapy. 27(1)
Forty-seven patients with metastatic disease at diagnosis or recurrent Ewing sarcoma (EWS) received high-dose chemotherapy (HDC) followed by tandem (n = 20, from February 13, 1997, to October 24, 2002) or single (n = 27, from October 1, 2004, to Sept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c281c1b4988ed52e875daab4e4d245b1
https://pubmed.ncbi.nlm.nih.gov/33007495
https://pubmed.ncbi.nlm.nih.gov/33007495
Autor:
Javier Oesterheld, Michael S. Isakoff, Rikesh J Makanji, Damon R. Reed, Tiffany Smith, Lars M. Wagner, Brooke L. Fridley, Patrick A. Thompson, David M. Loeb, Bhuvana A. Setty, Masanori Hayashi, Hong Yin
Publikováno v:
Pediatr Blood Cancer
BACKGROUND: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent sarcoma. Nab-paclitaxel is a taxane modified to improve drug exposure and increase intratumoral accumulation and, in combination with gemcitabine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f6c9f1236c42fb8800b1542aeeb214
https://doi.org/10.1002/pbc.28370
https://doi.org/10.1002/pbc.28370
Autor:
Amelie Dammann, Rudi Dierckx, Jelle Overbosch, Ömer Kasalak, Hugo J. A. Adams, Paul C Jutte, Thomas C. Kwee
Publikováno v:
Skeletal Radiology, 47(11), 1517-1522. SPRINGER
Skeletal radiology, 47(11), 1517-1522. Springer Verlag
Skeletal radiology, 47(11), 1517-1522. Springer Verlag
PURPOSE: To determine the frequency of locally recurrent Ewing sarcoma on surveillance MRI and the outcome of these patients.MATERIALS AND METHODS: This retrospective single-center study included all patients with newly diagnosed Ewing sarcoma who un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec2629549b8439e61b2c2fee3d55668
https://hdl.handle.net/11370/34ceb838-788e-4be9-9c5f-01201cb2b2a9
https://hdl.handle.net/11370/34ceb838-788e-4be9-9c5f-01201cb2b2a9
Autor:
Arnulfo Mendoza, Christine M. Heske, Joshua T. Baumgart, Len Neckers, David A. Proia, Leah D. Edessa, Jane B. Trepel, Sunmin Lee, Lee J. Helman
Publikováno v:
Oncotarget
// Christine M. Heske 1 , Arnulfo Mendoza 1 , Leah D. Edessa 1 , Joshua T. Baumgart 1 , Sunmin Lee 2 , Jane Trepel 2 , David A. Proia 3 , Len Neckers 4 , Lee J. Helman 1 1 Pediatric Oncology Branch, National Cancer Institute, National Institutes of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d4d468d10ccd499403a16f2286b6461
http://europepmc.org/articles/PMC5323173
http://europepmc.org/articles/PMC5323173
Autor:
Meera Hameed, Emily K. Slotkin, Leonard H. Wexler, Alexander J. Chou, Anita P. Price, Paul A. Meyers, Alex Kentsis, Heather Magnan, Ahmet Zehir, Jennifer Kennedy, Michael V. Ortiz, Suzanne L. Wolden, Todd E. Heaton, Srikanth R. Ambati, Neerav Shukla, Michael F. Berger, Leonard N. Girardi, Michael Walsh
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:e443-e445
A 16-year-old male was diagnosed with Ewing sarcoma of the ribcage with pulmonary metastases. Six months after completion of scheduled therapy, he was found to have a new intracardiac mass, presumed recurrent Ewing sarcoma. EWSR1 fusion was not detec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7024bbd1b6f6492198fe44521f107f9f
https://doi.org/10.1097/mph.0000000000000754
https://doi.org/10.1097/mph.0000000000000754
Autor:
Anna Paioli, Alessandro Parra, Alberto Righi, Luca Morandi, Stefano Ferrari, Elisabetta Setola, Lorenzo D'Ambrosio, Giovanni Grignani, Rossella Hakim, Massimo Eraldo Abate, Franca Fagioli, Marilena Cesari, Katia Scotlandi, Asaftei Dorin Sebastian, Davide Maria Donati, Alessandra Longhi, Michela Pasello, Maria Cristina Manara, Robin L. Jones, Emanuela Palmerini
Publikováno v:
Journal of Clinical Oncology. 38:e23564-e23564
e23564 Background: Activity of temozolomide (TEM) and irinotecan (IRI) in recurrent Ewing sarcoma (EWS) was demonstrated. Few data are available on TEMIRI use upfront. Biological predictive factors are lacking. Methods: This multi-institutional retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84d7274810c6f7e0ac1e3b6f6a775eec
https://doi.org/10.1200/jco.2020.38.15_suppl.e23564
https://doi.org/10.1200/jco.2020.38.15_suppl.e23564